Evidence map›Paper›PMID 38253492›Full record

ArticleAnnals of family medicine

Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer.

Archana Radhakrishnan, Lalita Subramanian, Aaron J Rankin, Michael D Fetters, Daniela A Wittmann, Kevin B Ginsburg, Sarah T Hawley, Ted A Skolarus

Open access · diamondAbstract read
In one paragraph

Article in Annals of family medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Archana RadhakrishnanDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan arra@med.umich.edu.
Lalita SubramanianDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Aaron J RankinDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Michael D FettersDepartment of Family Medicine, University of Michigan, Ann Arbor, Michigan.
Daniela A WittmannDepartment of Urology, University of Michigan, Ann Arbor, Michigan.
Kevin B GinsburgDepartment of Urology, Wayne State University, Detroit, Michigan.
Sarah T HawleyDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Ted A SkolarusDepartment of Urology, University of Chicago, Chicago, Illinois.
University of Michigan · USUniversity of Chicago · USWayne State University · US

Funding

De-implementation of low value castration for men with prostate cancerR37CA222885 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SAINI, SAMEER DEV, SKOLARUS, TED ALBERT · 2018 to 2023
$3.6M
Refining castration use for recurrent prostate cancerR01CA242559 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SKOLARUS, TED ALBERT, TSODIKOV, ALEXANDER · 2020 to 2023
$1.4M
Engaging PCPs to optimize active surveillance of low-risk prostate cancerK08CA245237 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RADHAKRISHNAN, ARCHANA · 2019 to 2023
$1.2M
NCI NIH HHS K08 CA245237NCI NIH HHS R01 CA242559NCI NIH HHS R37 CA222885
6 · The paper itself

Abstract

purposeWe conducted a study to understand primary care physician (PCP) and urologist perspectives on determinants of active surveillance care delivery for men with low-risk prostate cancer.

methodsWe conducted in-depth, semistructured, virtual interviews with a purposive sample of 19 PCPs and 15 urologists between June 2020 and March 2021. We used the behavioral theory-informed Theoretical Domains Framework to understand barriers to and facilitators of active surveillance care delivery. Interviews were recorded, transcribed, and deductively coded into framework domains and constructs by 3 independent coders. Participant recruitment continued until data saturation by group.

resultsOur study included 19 PCPs (9 female; 4 in community practices, 15 in academic medical centers) and 15 urologists (3 female; 5 in private practice, 3 in academic medical centers). The most commonly reported Theoretical Domains Framework domains affecting active surveillance care were (1) knowledge and (2) environmental context and resources. Although urologists were knowledgeable about active surveillance, PCPs mentioned limitations in their understanding of active surveillance (eg, what follow-up entails). Both groups noted the importance of an informed patient, especially how a patient's understanding of active surveillance facilitates their receipt of recommended follow-up. Physicians viewed patient loss to follow-up as a barrier, but identified a favorable organizational culture/climate (eg, good communication between physicians) as a facilitator.

conclusionsWith patients increasingly involving their PCPs in their cancer care, our study presents factors both PCPs and urologists perceive (or identify) as affecting optimal active surveillance care delivery. We provide insights that can help inform multilevel supportive interventions for patients, physicians, and organizations to ensure the success of active surveillance as a management strategy for low-risk prostate cancer.

Indexed as

Physicians, Primary CareProstatic NeoplasmsAcademic Medical CentersHumansMaleUrologistsWatchful Waitingbehavior changecontinuity of carecoordination of careimplementationinterdisciplinary communicationpatient care teamprimary health careprostatic neoplasmsqualitative researchsurveillanceurologists

Identifiers

PMID38253492
PMCPMC11233078
OpenAlexW4391116494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.